<p>This is a summary of the European public assessment report (EPAR) for Envarsus. It explains how the Agency assessed the medicine to recommend its authorisation in the EU and its conditions of use. It is not intended to provide practical advice on how to use Envarsus.</p><p>For practical information about using Envarsus, patients should read the package leaflet or contact their doctor or pharmacist.</p>
Therapeutic Indication
<div class="subsection mt-3-5"> <h3>Therapeutic indication</h3><p>Prophylaxis of transplant rejection in adult kidney or liver allograft recipients. Treatment of allograft rejection resistant to treatment with other immunosuppressive medicinal products in adult patients.</p></div>
Therapeutic Area (MeSH)
ATC Code
L04AD02
ATC Item
N/A
Pharmacotherapeutic Group
Immunosuppressants
Active Substance (Summary)
INN / Common Names
| Substance | CAS | Monograph |
|---|---|---|
| tacrolimus | N/A | tacrolimus |
EMA Name
Envarsus
Medicine Name
Envarsus
Aliases
N/ANo risk management plan link.
